• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥利司他,一种不可吸收、无热量的膳食脂肪替代品:综述。

Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review.

作者信息

Lawson K D, Middleton S J, Hassall C D

机构信息

Procter & Gamble Company, Winton Hill Technical Center, Cincinnati, Ohio 45224, USA.

出版信息

Drug Metab Rev. 1997 Aug;29(3):651-703. doi: 10.3109/03602539709037594.

DOI:10.3109/03602539709037594
PMID:9262944
Abstract

Olestra has been shown to be safe for its intended use by extensive testing in animals and in humans. It is not digested or absorbed and has no effect on the structure or physiology of the GI tract, the only organ of the body that it contacts. Olestra can interfere with the absorption of other lipophilic substances from the GI tract. The interference occurs because a portion of those molecules that are sufficiently lipophilic partition into the nonabsorbed olestra and is carried out of the body. Whether olestra will interfere with the absorption of a specific molecule can be predicted from the octanol-water partition coefficient of the molecule, a parameter that can be measured or calculated from a knowledge of the structure of the molecule. Olestra does not affect the absorption or efficacy of oral drugs because, in general, they are not sufficiently lipophilic to partition into the olestra. Olestra does not affect the absorption of water-soluble micronutrients or the absorption and utilization of macronutrients. Olestra can reduce the absorption of the fat-soluble vitamins when olestra foods and the vitamins are coingested. These effects can be offset by adding specific amounts of the vitamins to foods made with olestra. Other than the carotenoids and vitamins A and E, olestra does not affect the absorption of potentially beneficial components of fruits and vegetables. The effects on the vitamins can be offset by adding the vitamins to olestra foods. The reduction in the absorption of carotenoids will be less than 6-10% when olestra snacks are eaten under free-living dietary patterns. Any effect this reduction has on vitamin A status can be offset by addition of vitamin A to the foods. The absorption of flavonoids, polyphenols, and most other phytochemicals in fruits and vegetables, which have been shown to provide beneficial health effects, will not be affected by olestra because they are not sufficiently lipophilic. Individuals consuming large quantities of olestra may experience mild or moderate common GI symptoms such as loose or soft stools, gas, or nausea, symptoms similar to those experienced with certain other foods or changed dietary habits. When olestra snack foods are eaten under free-living dietary patterns, the symptoms are not different from those experienced when eating full-fat snack products, in either incidence or severity. When they are experienced, the symptoms resolve in 1-2 days, but may recur. They do not worsen with continued or increased olestra consumption and pose no health risk to the consumer. Olestra products will carry an information label alerting consumers to the possibility of GI symptoms. Olestra foods provide an additional option to those individuals who want or need to lower their total energy intake and body weight. These individuals will find it easier to change dietary habits and to maintain healthful nutritional practices when they use olestra foods. For those who want or need to reduce fat intake but not lose weight, olestra foods can reduce fat intake without affecting energy. Because olestra foods have taste and other organoleptic properties that are similar to those of full-fat foods, individuals will find it easier to switch to low-fat diets.

摘要

通过在动物和人体中的广泛测试,已证明奥利斯特拉在其预期用途上是安全的。它不会被消化或吸收,对胃肠道(它接触的身体唯一器官)的结构或生理功能没有影响。奥利斯特拉会干扰胃肠道中其他亲脂性物质的吸收。这种干扰的发生是因为那些足够亲脂的分子的一部分会分配到未被吸收的奥利斯特拉中并被带出体外。奥利斯特拉是否会干扰特定分子的吸收可以根据该分子的辛醇 - 水分配系数来预测,这是一个可以根据分子结构知识进行测量或计算的参数。奥利斯特拉不会影响口服药物的吸收或疗效,因为一般来说,它们的亲脂性不足以分配到奥利斯特拉中。奥利斯特拉不会影响水溶性微量营养素的吸收或常量营养素的吸收和利用。当同时摄入含奥利斯特拉的食物和脂溶性维生素时,奥利斯特拉会降低脂溶性维生素的吸收。通过在含奥利斯特拉的食物中添加特定量的维生素,可以抵消这些影响。除了类胡萝卜素以及维生素A和E外,奥利斯特拉不会影响水果和蔬菜中潜在有益成分的吸收。对维生素的影响可以通过在含奥利斯特拉的食物中添加维生素来抵消。在自由生活饮食模式下食用含奥利斯特拉的零食时,类胡萝卜素吸收的减少将小于6 - 10%。这种减少对维生素A状态的任何影响都可以通过在食物中添加维生素A来抵消。水果和蔬菜中的黄酮类化合物、多酚和大多数其他植物化学物质已被证明具有有益健康的作用,它们的吸收不会受到奥利斯特拉的影响,因为它们的亲脂性不足。大量食用奥利斯特拉的个体可能会出现轻度或中度的常见胃肠道症状,如腹泻或大便松软、胀气或恶心,这些症状与食用某些其他食物或改变饮食习惯时出现的症状相似。在自由生活饮食模式下食用含奥利斯特拉的零食时,症状在发生率或严重程度上与食用全脂零食产品时没有差异。当出现这些症状时,它们会在1 - 2天内消失,但可能会复发。它们不会随着奥利斯特拉摄入量的持续增加而恶化,对消费者也没有健康风险。奥利斯特拉产品将带有信息标签,提醒消费者注意胃肠道症状的可能性。含奥利斯特拉的食物为那些想要或需要降低总能量摄入和体重的个体提供了另一种选择。这些个体在使用含奥利斯特拉的食物时会发现更容易改变饮食习惯并保持健康的营养习惯。对于那些想要或需要减少脂肪摄入但又不想减肥的人来说,含奥利斯特拉的食物可以减少脂肪摄入而不影响能量。因为含奥利斯特拉的食物具有与全脂食物相似的味道和其他感官特性,个体将发现更容易转向低脂饮食。

相似文献

1
Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review.奥利司他,一种不可吸收、无热量的膳食脂肪替代品:综述。
Drug Metab Rev. 1997 Aug;29(3):651-703. doi: 10.3109/03602539709037594.
2
Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: summary.对蔗糖聚酯(一种不被吸收的脂肪替代品)营养作用的评估:总结。
J Nutr. 1997 Aug;127(8 Suppl):1719S-1728S. doi: 10.1093/jn/127.8.1719S.
3
Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: introduction and overview.
J Nutr. 1997 Aug;127(8 Suppl):1539S-1546S. doi: 10.1093/jn/127.8.1539S.
4
Evaluation of the potential for olestra to affect the availability of dietary phytochemicals.
J Nutr. 1997 Aug;127(8 Suppl):1699S-1709S. doi: 10.1093/jn/127.8.1699S.
5
Review article: olestra and its gastrointestinal safety.
Aliment Pharmacol Ther. 1998 Dec;12(12):1185-200. doi: 10.1046/j.1365-2036.1998.00415.x.
6
Olestra consumption does not predict serum concentrations of carotenoids and fat-soluble vitamins in free-living humans: early results from the sentinel site of the olestra post-marketing surveillance study.食用奥利斯特拉不能预测自由生活人群中类胡萝卜素和脂溶性维生素的血清浓度:奥利斯特拉上市后监测研究哨点的早期结果
J Nutr. 2000 Jul;130(7):1711-8. doi: 10.1093/jn/130.7.1711.
7
Olestra Postmarketing Surveillance Study: design and baseline results from the sentinel site.奥利斯特拉上市后监测研究:哨点的设计与基线结果
J Am Diet Assoc. 1998 Nov;98(11):1290-6. doi: 10.1016/S0002-8223(98)00289-2.
8
Safety evaluation of olestra, a nonabsorbed, fatlike fat replacement.蔗糖聚酯的安全性评估,一种不被吸收的类脂肪脂肪替代品。
Crit Rev Food Sci Nutr. 1992;32(2):141-6. doi: 10.1080/10408399209527588.
9
Olestra: a new food additive.
J Am Diet Assoc. 1998 May;98(5):565-9. doi: 10.1016/s0002-8223(98)00126-6.
10
Sensory properties of a nonabsorbable fat substitute did not affect regulation of energy intake.
Am J Clin Nutr. 1997 May;65(5):1375-83. doi: 10.1093/ajcn/65.5.1375.

引用本文的文献

1
Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.作者与食品饮料行业的财务关系以及他们对脂肪替代品蔗糖聚酯发表的立场。
Am J Public Health. 2003 Apr;93(4):664-9. doi: 10.2105/ajph.93.4.664.
2
Pharmacological approaches for the treatment of obesity.治疗肥胖症的药理学方法。
Drugs. 2002;62(6):915-44. doi: 10.2165/00003495-200262060-00005.
3
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.
影响口服给药后药物吸收的药物、食物及制剂相互作用。临床意义。
Clin Pharmacokinet. 1999 Mar;36(3):233-54. doi: 10.2165/00003088-199936030-00004.
4
The selling of olestra.奥利斯特拉的销售
Public Health Rep. 1998 Nov-Dec;113(6):508-20.